The Securities Arbitration Law Firm of Klayman & Toskes (“K&T”),
, announced today that it is investigating the sales practices of brokerage firms, including UBS Financial Services (NYSE: UBS), who sold the UBS Willow Fund to their customers. Last month, a class action lawsuit was filed on behalf of investors in the UBS Willow Fund. Eligible class members are encouraged to explore all of their legal options, including filing an individual securities arbitration claim against their full service brokerage firm who sold them the Fund.
The UBS Willow Fund is a private hedge fund, which was formed in 2000. In October of 2012 investors were notified that the Fund would be liquidated. While many investors were advised that the Fund was a safe, low risk product, the Fund has declined about 80%. Accordingly, K&T is investigating whether brokerage firms adequately disclosed the risks associated with the product, as well as whether investors’ portfolios were over-concentrated in the Fund. K&T has been contacted by Willow Fund investors who purchased the product from UBS Financial Services, and are preparing to file securities arbitration claims on their behalf.
Investors who have sustained losses in the UBS Willow Fund can contact K&T to explore their legal rights and options. The attorneys at K&T are dedicated to pursuing claims on behalf of investors who have suffered investment losses. K&T, an experienced, qualified and nationally recognized securities litigation law firm, practices exclusively in the field of securities arbitration and litigation. It continues its representation of investors throughout the world in securities arbitration and litigation matters against major Wall Street brokerage firms.
If you wish to discuss this announcement or have investment losses of $100,000 or more in the UBS Willow Fund, please contact Steven D. Toskes, Esquire or Jahan K. Manasseh, Esquire of Klayman & Toskes, P.A., at 888-997-9956 or visit us on the web at